MEVADOL FORTE (Apotex Pty Ltd)
Product name
MEVADOL FORTE
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
144 working days (255)
Active ingredients
codeine phosphate hemihydrate; doxylamine succinate; paracetamol
Registration type
New generic medicine
Indication
MEVADOL FORTE (tablets) is indicated for relief of severe pain not responding to milder analgesics.
MEVADOL FORTE is suitable for individuals who cannot tolerate aspirin.